第6章 ラウンドテーブルディスカッション「エンドトキシンや関連メディエーターをいかに測るか」
自動多項目同時遺伝子関連検査システムVerigene®システム 敗血症パネル
2020 年 23 巻 p. 83-86
詳細
2020 年 23 巻 p. 83-86
Sepsis Panel of Verigene® System is an automated multi-item genetic testing system that is able to simultaneously detect bacteria and drug resistance genes for the purpose of selecting therapeutic agents for patients with sepsis.
Verigene® System started selling in 2016 and is covered by insurance in June 2017.
Compared to the conventional method that took a long time, the Verigene® system enables 24-48 hours earlier than the existing method to identify major bacteria and to rapidly detect drug resistance genes. This enables faster and more effective and appropriate antibacterial drug selection in the treatment for sepsis.
